In every issue of HEP, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
As a peer educator, Gloria Guzman inspires others hoping for a hepatitis C cure.
Regardless of the hurdles many HCV-positive people face, there is a better chance to get cured than ever before.
Another explanation for hep C among baby boomers
People on Medicaid are less likely to be treated.
They are the first community in the United States to set this goal
An analysis from Harvard University
More difficult than getting drugs that cause addiction
Liver cancer incidence is steadily rising in the United States, driven by hepatitis B and C virus infection in an aging population.
The FDA expanded the approved uses of the combination hep C virus regimen of Bristol-Myers Squibb’s Daklinza and Gilead Sciences’ Sovaldi.
Using Gilead Sciences’ Harvoni to treat hep C in certain people is more cost effective than waiting until their liver disease progresses.
People with hep C virus (HCV) have higher rates of cardiovascular disease (CVD) than HCV-negative individuals with similar risk factors.
The FDA has approved Merck’s once-daily, fixed-dose combination tablet Zepatier to treat people with genotypes 1 and 4 of hep C.